Avid Bioservices Inc (CDMO)

[purpledawgs]

RRdog: If Roche is also interested in our cancer platform, then they have to know that giving us upfront money on HEP C makes it possible for us to push farther alone with Bavi for cancer. That would most likly make Bavi cancer a more expensive acquisition in the future. Do you really think they would buy/license them separately, or would they want the whole package at once?

PD